Citations

Clear

4847 citation(s) found for "Tu, Eric".

RNA‐seq analysis of clinical‐grade osteochondral allografts reveals activation of early response genes
Yang, Lin , Lewallen, Eric A. , Camilleri, Emily T. , Bonin, Carolina A. , Jones, Dakota L. , Dudakovic, Amel , Galeano‐Garces, Catalina , Wang, Wei , Karperien, Marcel , Larson, A. Noelle , Dahm, Diane L., Levy, Bruce A. , Smith, Jay , Ryssman, Daniel B., Im, Hee‐Jeong , Wijnen, André J. van , Riester, Scott M. , Krych, Aaron J. , Camilleri, Emily , Lin, Yang , Larson, Annalise N, van Wijnen, Andre J, Stuart, Michael J. , Westendorf, Jennifer J. , van Wijnen, Andre J , Krych, Aaron J , Larson, A Noelle , Camilleri, Emily

Mayo Clinic

Journal of Orthopaedic Research | February 25, 2016 | Volume: 34 | Issue: 11 | Pages: 1950-1959

10.1002/jor.23209 | PMID 26909883 Get It

ABSTRACTPreservation of osteochondral allografts used for transplantation is critical to ensure favorable outcomes for patients after surgical treatment of cartilage defects. To study the biological effects of protocols currently used for cartilage storage, we investigated differences in gene expression between stored allograft cartilage and fresh cartilage from living donors using high throughput molecular screening strategies. We applied next generation RNA sequencing (RNA‐seq) and real‐time reverse transcription quantitative polymerase chain reaction (RT‐qPCR) to assess genome‐wide differences in mRNA expression between stored allograft cartilage and fresh cartilage tissue from living donors. Gene ontology analysis was used to characterize biological pathways associated with differentially expressed genes. Our studies establish reduced levels of mRNAs encoding cartilage related extracellular matrix (ECM) proteins (i.e., COL1A1, COL2A1, COL10A1, ACAN, DCN, HAPLN1, TNC, and COMP) in stored cartilage. These changes occur concomitantly with increased expression of “early response genes” that encode transcription factors mediating stress/cytoprotective responses (i.e., EGR1, EGR2, EGR3, MYC, FOS, FOSB, FOSL1, FOSL2, JUN, JUNB, and JUND). The elevated expression of “early response genes” and reduced levels of ECM‐related mRNAs in stored cartilage allografts suggests that tissue viability may be maintained by a cytoprotective program that reduces cell metabolic activity. These findings have potential implications for future studies focused on quality assessment and clinical optimization of osteochondral allografts used for cartilage transplantation. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1950–1959, 2016.
Impact of Electronic-Alerting of Acute Kidney Injury: Workgroup Statements from the 15 th ADQI Consensus Conference
Hoste, Eric A. J. , Wilson, F. Perry , Ronco, Claudio , Goldstein, Stuart L. , Bagshaw, Sean M. , Group, on behalf of the 15 ADQI Consensus, Kashani, Kianoush , Gibney, R. T. Noel , Kellum, John A. , Group, on behalf of the 15 ADQI Consensus, Wilson, F Perry , Ronco, Claudio , Bagshaw, Sean M

Mayo Clinic

Canadian Journal of Kidney Health and Disease | February 19, 2016 | Volume: 3 | Issue: No issue available | Pages: No page available

10.1186/s40697-016-0101-1 | PMID 26925246 Get It

Purpose of the review: Among hospitalized patients, acute kidney injury is common and associated with significant morbidity and risk for mortality. The use of electronic health records (EHR) for prediction and detection of this important clinical syndrome has grown in the past decade. The steering committee of the 15 th Acute Dialysis Quality Initiative (ADQI) conference dedicated a workgroup with the task of identifying elements that may impact the course of events following Acute Kidney Injury (AKI) e-alert. Sources of information: Following an extensive, non-systematic literature search, we used a modified Delphi process to reach consensus regarding several aspects of the utilization of AKI e-alerts. Findings: Topics discussed in this workgroup included progress in evidence base practices, the characteristics of an optimal e-alert, the measures of efficacy and effectiveness, and finally what responses would be considered best practices following AKI e-alerts. Authors concluded that the current evidence for e-alert system efficacy, although growing, remains insufficient. Technology and human-related factors were found to be crucial elements of any future investigation or implementation of such tools. The group also concluded that implementation of such systems should not be done without a vigorous plan to evaluate the efficacy and effectiveness of e-alerts. Efficacy and effectiveness of e-alerts should be measured by context-specific process and patient outcomes. Finally, the group made several suggestions regarding the clinical decision support that should be considered following successful e-alert implementation. Limitations: This paper reflects the findings of a non-systematic review and expert opinion. Implications: We recommend implementation of the findings of this workgroup report for use of AKI e-alerts.
Evaluation of Clinical Outcomes of Osseointegrated Dental Implantation of Fibula Free Flaps for Mandibular Reconstruction
Jackson, Ryan S. , Arce, Kevin , Moore, Eric J. , Price, Daniel L.

Mayo Clinic

JAMA Facial Plastic Surgery | February 11, 2016 | Volume: 18 | Issue: 3 | Pages: 201-206

10.1001/jamafacial.2015.2271 | PMID 26868226 Get It

A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin
Sowd, Gregory A. , Serrao, Erik , Wang, Hao , Fadel, Hind J., Poeschla, Eric M. , Engelman, Alan , Wang, Weifeng

Mayo Clinic

Proceedings of the National Academy of Sciences | February 9, 2016 | Volume: 113 | Issue: 8 | Pages: No page available

10.1073/pnas.1524213113 | PMID 26858452 Get It

Significance HIV-1 requires integration for efficient gene expression, and the local chromatin environment significantly influences the level of HIV-1 transcription. Silent, integrated proviruses constitute the latent HIV reservoir. As HIV-1 commandeers cellular factors to dictate its preferred integration sites, these interactions consequentially influence latency. We examined the impact of polyadenylation specificity factor CPSF6, which binds HIV-1 capsid, and the integrase-binding chromatin reader LEDGF/p75 on viral infection and integration site distribution. Integration sites were determined in cells knocked down or knocked out for one or both host factors. Our data indicate that CPSF6 directs HIV-1 to transcriptionally active chromatin, where LEDGF/p75 predominantly directs the positions of integration within genes. These findings clarify the roles of cellular forces that dictate HIV-1 integration preferences and hence virus pathogenesis.
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Renfro, Lindsay A. , Kerr, David , Gramont, Aimery de , André, Thierry , Guthrie, Katherine A. , Labianca, Roberto , Francini, Guido, Seitz, J. F., O’Callaghan, Chris J. , Twelves, Chris , Haller, Daniel G. , Yothers, Greg , Cheung, Winson Y, de Gramont, Aimery, Saltz, Leonard B. , O'Callaghan, Chris, van Cutsem, Eric, Cheung, Winson Y. , Grothey, Axel , Alberts, Steven R. , Cutsem, Eric Van , Sargent, Daniel J. , André, Thierry , Yothers, Greg

Mayo Clinic

Journal of Clinical Oncology | February 9, 2016 | Volume: 34 | Issue: 11 | Pages: 1182-1189

10.1200/jco.2015.65.1158 | PMID 26858337 Get It

Purpose Factors associated with early mortality after surgery and treatment with adjuvant chemotherapy in colon cancer are poorly understood. We aimed to characterize the determinants of early mortality in a large cohort of colon cancer trial participants. Methods A pooled analysis of 37,568 patients in 25 randomized trials of adjuvant systemic therapy was conducted. Multivariable logistic regression models with several definitions of early mortality (30, 60, and 90 days, and 6 months) were constructed, adjusting for clinically and statistically significant variables. A nomogram for 6-month mortality was developed and validated. Results Median age among patients was 61 years, patient demographics included 54% men and 90% White, 29% and 71% had stage II and III disease, respectively, and 79%, 20%, and 1% had an Eastern Cooperative Oncology Group performance status (PS) of 0, 1, and ≥ 2, respectively. Early mortality was low: 0.3% at 30 days, 0.6% at 60 days, 0.8% at 90 days, and 1.4% at 6 months. Of those patients who died by 6 months post–random assignment, 40% had documented disease recurrence prior to death. Early disease recurrence was associated with a markedly increased risk of death during the first 6 months post-treatment (hazard ratio, 82.6; 95%CI, 66.9 to 102.1). In prognostic analyses, advanced age, male sex, poorer PS, increasing ratio of positive to examined lymph nodes, earlier decade of enrollment, and higher tumor stage and grade predicted a greater likelihood of early mortality, whereas treatment received was not strongly predictive. A multivariable model for 6-month mortality showed strong optimism-adjusted discrimination (concordance index, 0.73) and calibration. Conclusion Early mortality was infrequent but more prevalent in patients with advanced age and a PS of ≥ 2, underscoring the need to carefully consider the risk-to-benefit ratio when making treatment decisions in these subgroups.
Are Zebras Simply Striped Horses?
Lane, Colleen E. , Olson, Eric J. , Gersh, Bernard J. , Michelena, Héctor I.

Mayo Clinic

Circulation | January 25, 2016 | Volume: 133 | Issue: 4 | Pages: 434-441

10.1161/circulationaha.115.018730 | PMID 26811273 Get It

Off-Ice Anaerobic Power Does Not Predict On-Ice Repeated Shift Performance in Hockey
Peterson, Ben , Fitzgerald, John S. , Dietz, Calvin C., Ziegler, Kevin S., Baker, Sarah E. , Snyder, Eric M., Peterson, Ben J, Baker, Sarah E

Mayo Clinic

Journal of Strength and Conditioning Research | January 24, 2016 | Volume: 30 | Issue: 9 | Pages: 2375-2381

10.1519/jsc.0000000000001341 | PMID 26808844 Get It

Abstract Peterson, BJ, Fitzgerald, JS, Dietz, CC, Ziegler, KS, Baker, SE, and Snyder, EM. Off-ice anaerobic power does not predict on-ice repeated shift performance in hockey. J Strength Cond Res 30(9): 2375–2381, 2016—Anaerobic power is a significant predictor of acceleration and top speed in team sport athletes. Historically, these findings have been applied to ice hockey although recent research has brought their validity for this sport into question. As ice hockey emphasizes the ability to repeatedly produce power, single bout anaerobic power tests should be examined to determine their ability to predict on-ice performance. We tested whether conventional off-ice anaerobic power tests could predict on-ice acceleration, top speed, and repeated shift performance. Forty-five hockey players, aged 18–24 years, completed anthropometric, off-ice, and on-ice tests. Anthropometric and off-ice testing included height, weight, body composition, vertical jump, and Wingate tests. On-ice testing consisted of acceleration, top speed, and repeated shift fatigue tests. Vertical jump (VJ) ( r = −0.42; r = −0.58), Wingate relative peak power (WRPP) ( r = −0.32; r = −0.43), and relative mean power (WRMP) ( r = −0.34; r = −0.48) were significantly correlated ( p ≤ 0.05) to on-ice acceleration and top speed, respectively. Conversely, none of the off-ice tests correlated with on-ice repeated shift performance, as measured by first gate, second gate, or total course fatigue; VJ ( r = 0.06; r = 0.13; r = 0.09), WRPP ( r = 0.06; r = 0.14; r = 0.10), or WRMP ( r = −0.10; r = −0.01; r = −0.01). Although conventional off-ice anaerobic power tests predict single bout on-ice acceleration and top speed, they neither predict the repeated shift ability of the player, nor are good markers for performance in ice hockey.
New and Appropriate Goals for Parkinson Disease Physical Therapy
Ahlskog, J. Eric

Mayo Clinic

JAMA Neurology | January 19, 2016 | Volume: 73 | Issue: 3 | Pages: 269

10.1001/jamaneurol.2015.4449 | PMID 26785221 Get It

Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women
Zeitler, Emily P. , Hellkamp, Anne S., Schulte, Phillip J. , Fonarow, Gregg C. , Sanders, Gillian D, Hernandez, Adrian F. , Yancy, Clyde W. , Al-Khatib, Sana M, Peterson, Eric D. , Al‐Khatib, Sana M.

Mayo Clinic

Circulation: Heart Failure | January 13, 2016 | Volume: 9 | Issue: 1 | Pages: No page available

10.1161/circheartfailure.115.002630 | PMID 26758365 Get It

Background— Clinical trials of implantable cardioverter defibrillators (ICDs) for primary prevention enrolled a limited number of women. We sought to examine clinical practice data to compare survival rates among women with heart failure with or without a primary prevention ICD. Methods and Results— We linked data from 264 US hospitals included in the Get With The Guidelines for Heart Failure registry with data from the Centers for Medicare and Medicaid Services. From these sources, we propensity score matched 430 women with heart failure who received a primary prevention ICD to 430 women who did not; we further adjusted using a Cox proportional hazards model. Median follow-up was 3.4 and 3.0 years. For comparison, we matched 859 men receiving an ICD with 859 who did not; median follow-up was 3.9 versus 2.9 years. In the matched cohorts, an ICD was associated with similarly better survival in women (hazard ratio, 0.78; 95% confidence interval, 0.66–0.92; P =0.003) and men (hazard ratio, 0.76; 95% confidence interval, 0.67–0.87 P <0.001). There was no interaction between sex and presence of an ICD with respect to survival ( P =0.79). Conclusions— Among patients with heart failure with reduced left ventricular ejection fraction, a primary prevention ICD was associated with a significant survival advantage among women and among men. These findings support guideline-directed use of primary prevention ICDs in eligible patients.